Institutional Ownership Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX). We have compiled data on the 367 institutions that hold shares in the stock, with a total of 288 Million shares, which have been reported (via 13F filing form) to have a value of $1.35 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
First Trust Advisors LP
Wheaton, IL |
Aug 13, 2025 Q2 2025 |
1,880,290
shares
|
$8.76 Million
0.01% of portfolio
|
Q2 2025
Added 82.29%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,378,915
shares
|
$6.43 Million
0.0% of portfolio
|
Q2 2025
Added 7.31%
|
|
|
Vestmark Advisory Solutions, Inc.
|
Aug 06, 2025 Q2 2025 |
1,339,139
shares
|
$6.24 Million
0.11% of portfolio
|
Q2 2025
Added 89.62%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,314,552
shares
|
$6.13 Million
0.0% of portfolio
|
Q2 2025
Reduced 50.5%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
1,225,658
shares
|
$5.71 Million
0.0% of portfolio
|
Q2 2025
Reduced 35.92%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,167,813
shares
|
$5.44 Million
0.01% of portfolio
|
Q2 2025
Added 1.32%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,164,689
shares
|
$5.43 Million
0.0% of portfolio
|
Q2 2025
Added 97.07%
|
|
|
Jump Financial, LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,151,201
shares
|
$5.36 Million
0.07% of portfolio
|
Q2 2025
Added 94.34%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,131,218
shares
|
$5.27 Million
0.0% of portfolio
|
Q2 2025
Reduced 24.38%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,069,950
shares
|
$4.99 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.79%
|
|
|
Comprehensive Financial Management LLC
Los Gatos, CA |
Aug 12, 2025 Q2 2025 |
941,895
shares
|
$4.39 Million
0.13% of portfolio
|
Q3 2023
Reduced 15.1%
|
|
|
Iq Eq Fund Management (Ireland) LTD
|
Aug 01, 2025 Q2 2025 |
911,085
shares
|
$4.25 Million
0.42% of portfolio
|
Q2 2025
Added 135.28%
|
|
|
Two Sigma Ventures, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
903,400
shares
|
$4.21 Million
100.0% of portfolio
|
Q3 2022
Reduced 50.0%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
818,324
shares
|
$3.81 Million
0.0% of portfolio
|
Q1 2025
Reduced 22.59%
|
|
|
Mv Management Xi, L.L.C.
|
Nov 14, 2023 Q3 2023 |
788,762
shares
|
$3.68 Million
10.04% of portfolio
|
Q3 2023
Reduced 60.0%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
739,408
shares
|
$3.45 Million
0.0% of portfolio
|
Q2 2025
Added 47.26%
|
|
|
Capital Fund Management S.A.
Paris, I0 |
Aug 13, 2025 Q2 2025 |
720,526
shares
|
$3.36 Million
0.01% of portfolio
|
Q2 2025
Added 247.63%
|
|
|
Nan Fung Group Holdings LTD
Central, K3 |
Aug 13, 2025 Q2 2025 |
664,610
shares
|
$3.1 Million
6.38% of portfolio
|
Q4 2024
New holding
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
633,403
shares
|
$2.95 Million
0.0% of portfolio
|
Q2 2025
Added 939.97%
|
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
631,206
shares
|
$2.94 Million
0.14% of portfolio
|
Q2 2025
New holding
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
595,518
shares
|
$2.78 Million
2.85% of portfolio
|
Q4 2024
New holding
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
544,159
shares
|
$2.54 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
517,255
shares
|
$2.41 Million
0.0% of portfolio
|
Q2 2025
Added 44.01%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
483,300
shares
|
$2.25 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.7%
|
|
|
Virtu Financial LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
449,092
shares
|
$2.09 Million
0.12% of portfolio
|
Q2 2025
Added 1219.46%
|